Active Ingredient History

NOW
  • Now
Tivozanib, sold under the brand name Fotivda, is a medication used for the treatment of relapsed or refractory advanced renal cell carcinoma (RCC). It is an oral VEGF receptor tyrosine kinase inhibitor.   Wikipedia

  • SMILES: COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC
  • InChIKey: SPMVMDHWKHCIDT-UHFFFAOYSA-N
  • Mol. Mass: 454.87
  • ALogP: 5.64
  • ChEMBL Molecules:
More Chemistry
asp-4130 | av 951 | av-951 | av951 cpd | kil8951 | kil-8951 | krn951 | krn 951 | krn-951 | tivozanib | tivozanib hcl | tivozanib hydrochloride

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue